Gregory Grabowski, DPM
Foot & Ankle Surgery · Bellevue, WANPI 1649335019
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $33,699 of the $34,250 with a category attached, or 98.4%. Orthofix Medical, Inc. accounts for 98.6% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2021 at $10,204 and has fallen 63.7% since, to $3,702 in 2025. Among foot & ankle surgery clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 39 payments — averaging $878.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Orthofix Medical, Inc.$34K
- Stryker$163
- Nevro Corp.$96
- Organogenesis Inc.$71
- Amgen$44
- Access Pro Medical, LLC$43
- plus $59 from 4 others
What the payments were for
- Royalty or licence$33,69998%
- Food & beverage$5512%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Orthofix Medical, Inc. | 23 | $33,774 |
| Stryker | 2 | $163 |
| Nevro Corp. | 2 | $96 |
| Organogenesis Inc. | 4 | $71 |
| Amgen | 3 | $44 |
| Access Pro Medical, LLC | 1 | $43 |
| Fusion Orthopedics USA, LLC | 1 | $16 |
| Invictus Surgical Incorporated | 1 | $15 |
| Reprise Biomedical, Inc. | 1 | $14 |
| Abbott | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MiniRail System$27,009
- M2 Multiplanar MiniRail$4,895
- Physio-Stim$3,606
- Calcaneal Minifixator$3,084
- AUGMENT INJECTABLE$123
- EASYFUSE$123
- ORTHOLOC 2 LAPIFUSE$123
- CITREFIX$123
How this compares
$34,250 in reported general payments places this provider in the 95th percentile of 203 foot & ankle surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 49 | $675 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $259 |
| Meloxicam | 44 | $223 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $183 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 34 | $169 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 13 | $137 |
| Terbinafine Hcl | 13 | $134 |
| Ibuprofen | 11 | $99 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Bellevue
- Bryan HolandBellevue$26K
- Jeffrey ChristensenEverett$828K
- David DalstromSeattle$491K
- Richard LamourOlympia$87K
- Adam AlbabaSeattle$46K
- Stephen BenirschkeSeattle$45K
- Craig CliffordFederal Way$44K
- Shawn KhademiRenton$43K
- Jacob McLeodLongview$34K
- Garrett PereskoMorton$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.